BackTissue Regenix Group plc Overview

Tissue Regenix Group plc Receivables

Tissue Regenix Group plc's receivables is $4.4M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$4.38M
↑ 44.63% YoYΔ $1.35M vs prior year quarter

Peer trimmed avg / median

Loading

Tissue Regenix Group plc Receivables History

Loading

Tissue Regenix Group plc vs. peers: Receivables Comparison

Loading

Tissue Regenix Group plc Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Tissue Regenix Group plc (TSSNF) FAQ

Tissue Regenix Group plc (TSSNF) currently reports a receivables of $4.4M as of December 2024. That compares with $3M in the prior-year period — up 44.6% year over year. Use the charts on this page to explore Tissue Regenix Group plc's receivables history and peer comparisons.

Tissue Regenix Group plc's receivables increased from $3M to $4.4M — a 44.6% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tissue Regenix Group plc reported $4.4M in receivables as of December 2024. That compares with $3M in the prior-year period — up 44.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $4.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tissue Regenix Group plc, and consider following TSSNF for alerts when major investors trade the stock.